Global Clinical Decision Support System Market Size, Share, Growth Analysis, By Product(Standalone CDSS, Integrated CPOE with CDSS), By Application(Drug-drug Interactions, Drug Allergy Alerts), By Deployment Mode(Web-based Systems, Cloud-based Systems), By Component(Hardware, Software) - Industry Forecast 2022-2028

Global Clinical Decision Support System Market is segmented based on Product, Application, Delivery Mode, Component, and Region. Based on Product the Clinical Decision Support System Market is further sub segmented into Standalone CDSS, Integrated CPOE with CDSS, Integrated E.H.R. with CDSS, Integrated CDSS with CPOE & E.H.R. Based on Application the Clinical Decision Support System Market is further sub segmented into Drug-drug Interactions, Drug Allergy Alerts, Clinical Reminders, Clinical Guidelines, Drug Dosing Support, Others , Based on Delivery Mode the Clinical Decision Support System Market is further sub segmented into Web-based Systems, Cloud-based Systems, On-premise Systems. Based on Component the Clinical Decision Support System Market is further sub segmented into Hardware, Software, Services. Based on Region the Clinical Decision Support System Market is further sub-segments into North America, Europe, Asia Pacific, Latin America, MEA.

Clinical Decision Support System Market Analysis Based on Product

Due to its simplicity and low cost, standalone CDSS held the greatest revenue share of nearly 30.0% in 2021. Its expansion has been facilitated by its simplicity of usage in clinical and hospital settings. For the whole duration of the forecast, the standalone category will continue to rule the market. Products from CDSS can be purchased independently, in conjunction with EHR or CPOE, or both.

Over the projected period, it is expected that the integrated EHR with CDSS segment will grow profitably. The multi-specialty healthcare units' growing awareness and EHR adoption is expected to have an impact on the segment's growth for integrated EHR with CDSS. When CDS systems and EHR are combined, the patient information and medical history are given to CDSS, which can then offer clinical advice and suggest treatments to the practitioner, automating the clinical workflow. To simplify processes and take advantage of current data sets, CDSS and EHRs are frequently connected. A growing number of CDSS features are being incorporated into EHR systems, which is expected to boost segment expansion.

Clinical Decision Support System Market Analysis Based on Application

In 2021, drug allergy alerts accounted for the greatest revenue portion (25.0%). Many people have allergies to particular medications, therefore it's critical to have systems that deliver allergy alerts. Drug allergies, as a subset of allergies, are becoming more prevalent. A medication error may occur during the prescribing, dispensing, or administration of a drug and may have negative consequences, such as the administration of medication to a patient who has a known drug allergy.

Over the projection period, the clinical guidelines segment is expected to increase profitably. The CDS system provides recommendations for both diagnosis and treatment. It pulls information from the knowledge base and uses it for treatment, giving the practitioner practical recommendations to follow throughout the duration of the treatment. This raises the standard of care.

Clinical Decision Support System Market Analysis Based on Component

In 2021, the services sector had the highest revenue share at nearly 40.0%. This is as a result of regular programme updates and the usable knowledge base. The upkeep of parts and their accessories falls under the category of CDSS services. It offers a knowledge database with the newest inventions and drugs, as well as hardware and software upgrades.

Over the projected period, it is expected that the software segment will grow profitably. The CDSS software offers improved decision assistance by producing tailored and unique outcomes for the given patient when used in connection with software for CPOE and EHRs. Over the course of the forecast period, new developments in technical support and software compatibility are predicted to drive the market.

Clinical Decision Support System Market Analysis Based on Delivery mode

In terms of revenue share, the on-premise systems market accounted for more than 40.0% in 2021. In 2021, cloud-based solutions had the second-highest revenue share because of major information technology advancements that could find use in the healthcare industry. Major drivers of this segment's growth include cost effectiveness and dependability. Platform as a Service (PaaS), which develops an operating system to run the software, Infrastructure as a Service (IaaS), which uses virtual technology to create a user interface to provide the services, and Software as a Service (SaaS), which is the most crucial component of the cloud provider as it enables them to run, install, and manage software to provide services to the end user, are the three main services provided under cloud computing.

A large portion of the global market for clinical decision support systems is expected to be dominated by North America due to the region's higher adoption of clinical decision systems by healthcare organisations. In addition, the introduction of new technologies to integrate existing data handling systems, such as EHR and clinical decision systems, are providing patients with predictive scenarios, which are responsible for better patient experience and treatment.

Due to the region's rapidly expanding patient population and growing demand for software assistance in managing this expanding patient population, Asia Pacific has enormous potential for growth of the world's clinical decision support systems. Additionally, it is expected that increased cooperation between healthcare organisations and information technology firms for the development of new systems will accelerate the growth of clinical decision support systems globally in the Asia Pacific region.

Clinical Decision Support System Market Driver

• The European Union's health ministers agreed to work together and create an eHealth common area in 2021, allowing for the free flow of electronic health records throughout the continent. The declaration also urges the inclusion of eHealth as a key component of the Europe 2021 strategy. Such policies/initiatives are expected to increase the demand for and uptake of EHR, which will have an impact on the uptake of CDSS in important global markets.

Clinical Decision Support System Market Restraint

• The global clinical decision support systems market is expected to experience growth challenges due to healthcare resources' resistance to install and run clinical decision support systems.
• The global market for clinical decision support systems is expected to experience significant growth restraints due to higher software installation and post-sale support costs.

The market is indeed not overly highly competitive. The market has been distinguished by the presence of prominent participants as well as other clinical decision support system suppliers. To gain a competitive advantage over one another, these players engage in new product launches, product innovations, acquisitions, and partnerships.

For instance, Change Healthcare unveiled InterQual 2021 in April 2021, the most recent iteration of the company's premier CDS solution. This update includes a significant amount of evidence-based content updates and enhancements, including new COVID-19 patient guidance, discussion of social determinants of health, and appropriate use of telehealth. It also includes four novel Medicare criteria elements. Additionally, DHIndia announced a collaboration with [email protected] & HealtheLife to create a CDSS for the screening of COVID-19 in May 2021. A front-line doctor's simple triage application was also created as part of the agreement. In the market for clinical decision support systems (CDSS), some significant companies are

Clinical Decision Support System Market Top Player’s Company Profiles

• Wolters Kluwer Health (US)
• Hearst Health (US)
• Elsevier B.V. (The Netherlands)
• Cerner Corporation (US)
• McKesson Corporation (Change Healthcare) (US)
• Epic Systems Corporation (US)
• MEDITECH (US)
• Philips Healthcare (The Netherlands)
• International Business Machines (IBM) (US)
• Allscripts Healthcare Solutions, Inc. (US)

Clinical Decision Support System Market Recent Development

• Change Healthcare (US) and the American Society of Addiction Medicine jointly launched InterQual in 2021. (ASAM). Utilizing industry-standard criteria, InterQual seamlessly integrates into current care-management workflows, drastically cuts the time needed for patient assessments of substance use disorder (SUD), improves consistency, and streamlines the prior-authorization process.
• An expansion of Allscripts SunriseTM electronic health records (EHR) to Victoria, Australia, and Gippsland was announced by the GHA in 2021. The Sunrise Emergency Care module (part of the Sunrise EHR platform of health) will be put into place at the emergency departments of the Central Gippsland Health Service, Bairnsdale Regional Health Service (servicing east Gippsland), West Gippsland Healthcare Group, and Bass Coast Health, which covers the southern part of the region, during Phase 3 of GHA's EHR Community Health project.

• The growth of partnerships between CDSS providers and hospitals has significantly increased during the last few years. The demand is expected to rise even more as a result of government recognition and activities to promote the deployment of CDSS and EHR systems. By lowering the amount of time spent looking up a patient's medical history and records, integration with electronic health records (EHR) increases the effectiveness of clinical care. Additionally, the Health and Medicare Acts of the United States Government have approved CDSS, financially rewarding CDS integration into EHRs (Electronic Health Records). A CDSS was present in approximately 41% of American hospitals with an EHR in 2021, and a cutting-edge CDS was available in 40.2% of American hospitals in 2021. Additionally, businesses collaborate to create and offer software that is updated with the most recent data.

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected using Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, the standalone CDSS dominated the global Clinical Decision support System Market in 2021 and is expected to maintain its dominance throughout the forecast period. In 2021, the North America dominated the global Clinical Decision support System Market owing to the region's highly aware and economically stable population.